Kotak Mahindra Mutual Fund placed a considerable block deal in Ami Organics on May 19, 2025, and acquired over 13 lakh shares amounting to ₹150 crore.
Kotak Mutual Fund Executes Huge Bulk Deal in Ami Organics on 19th May, 2025
In a high-profile bulk deal indicating bullishness in the space of specialty chemicals, Kotak Mahindra Mutual Fund executed a significant bulk deal on May 19, 2025, by purchasing over 13.48 lakh shares of Ami Organics Limited (AMIORG).
The deal, which was done on the NSE, involved the acquisition of exactly 1,348,921 shares at an average trade value of ₹1115.00 a share, with a cumulative deal size of approximately ₹150.4 crore.
Mutual Funds Bets on Chemicals’ Growth
More Read
This huge deal by Kotak Mahindra Mutual Fund is a reflection of increasing institutional faith in the long-term future of Ami Organics. With its impressive portfolio of premium pharma intermediates and speciality chemicals, Ami Organics has been the mutual fund and foreign institutional investor (FII) darlings of recent quarters.
With growing demand for specialty chemicals and the changing role of India as a worldwide counterpoint to Chinese suppliers, the sector still enjoys robust investment traction. Mutual funds are noticeably getting ahead of projected growth cycles, and Kotak’s move is a case of strategic accumulation.
Strategic Investment Timing
The timing of the deal is intriguing, as it comes ahead of quarterly earnings and a broader sectoral rally. The investment by the mutual fund can be triggered by expectations of robust top-line performance and margin expansion by Ami Organics in the coming quarters.
Market analysts indicate that this transaction can also trigger fresh buying interest in the counter by retail and institutional investors.
Summary of the Bulk Deal
| Buyer | Kotak Mahindra Mutual Fund |
| Stock Symbol | AMIORG |
| Quantity Traded | 1,348,921 Shares |
| Trade Price | ₹1115.00 |
| Deal Value | ₹150.4 Crore |
| Exchange | NSE |
| Date of Transaction | May 19, 2025 |
As mutual funds continue to reshape their portfolios in 2025, deals like these underline the growing focus on high-growth sectors, and the increasing relevance of bulk deals as early indicators of institutional strategy shifts.
